Results 201 to 210 of about 910,981 (387)

An Autopsy Case of Agranulocytosis with Severe Candida Infection of the Upper Respiratory Tract and the Esophagus

, 1966
Tadafumi Hagihara
openalex   +2 more sources

Nonvalue of sputum culture in the management of lower respiratory tract infections [PDF]

, 1987
Joseph R. Lentino, David A. Lucks
openalex   +1 more source

Manganese Neurotoxicity and Familial Disorders of Manganese Transport

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Manganese is the 12th most common element in the Earth's crust and is an essential industrial component. Biologically, this metal plays an important role as a constituent of numerous enzymes. While manganese is required for normal biochemical and physiological processes, manganese excess can lead to significant toxicity, particularly to the ...
Sidney M. Gospe Jr.
wiley   +1 more source

Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections: a matched case-control study

The Lancet Respiratory Medicine, 2019
W. H. Man, M. V. van Houten, M. Mérelle, A. Vlieger, M. L. Chu, N. Jansen, E. Sanders, D. Bogaert   +7 more
semanticscholar   +1 more source

Kartagener’s Syndrome

Gomal Journal of Medical Sciences, 2004
Lower respiratory tract infections are a common problem in our society. In recurrent lower respiratory tract infections the cause may be either general impairment of immune mechanism, abnormalities of mucus or abnormalities of cilia.
Ihsan-ullah Mahsud, Shahab ud Din
doaj  

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

Clinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou, Rohit Rao, Monica E. Shapiro, Nessy Tania, Cody Herron, Cynthia J. Musante, Jim H. Hughes   +6 more
wiley   +1 more source

Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections

Journal of the American Medical Association (JAMA), 2017
J. Gerber, J. Gerber, Rachael K. Ross, M. Bryan, A. Localio, J. Szymczak, R. Wasserman, Darlene Barkman, Folasade Odeniyi, Kathryn Conaboy, L. Bell, T. Zaoutis, T. Zaoutis, A. Fiks, A. Fiks   +14 more
semanticscholar   +1 more source

Respiratory tract infections [PDF]

Clinical Microbiology and Infection, 1999
openaire   +1 more source

Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity

Clinical Pharmacology &Therapeutics, EarlyView.
Polymyxins are used against highly resistant Gram‐negative pathogens, and nephrotoxicity (acute kidney injury, AKI) is the major dose‐limiting adverse effect. We aimed to develop a well‐informed population pharmacokinetic/toxicodynamic (PK/TD) model using the largest polymyxin B‐treated critically ill patient population studied to inform polymyxin B ...
Patrick O. Hanafin, Ramya Mahadevan, Gauri G. Rao, Alexandre P. Zavascki, Ana Maria Sandri, Andrea Kwa, Marc H. Scheetz, Christine J. Kubin, Jayesh Shah, Benjamin P.Z. Cherng, Michael T. Yin, Jiping Wang, Lu Wang, David P. Calfee, Maureen Bolon, Anthony W. Purcell, Roger L. Nation, Jason M. Pogue, Jian Li, Keith S. Kaye   +19 more
wiley   +1 more source

Probiotics for preventing acute upper respiratory tract infections

Cochrane Database of Systematic Reviews, 2015
Q. Hao, B. Dong, Taixiang Wu
semanticscholar   +1 more source